The American College of Allergy, Asthma, and Immunology has issued updated guidelines on seasonal allergic rhinitis treatment.
Using biomarkers in pulmonary arterial hypertension may be a less invasive strategy for assessing response to treatment.
A significant improvement in lung function and annual asthma exacerbation rate was noted vs placebo.
Results of two phase 3 studies found that nivolumab provided superior overall survival vs docetaxel in people with non-small cell lung cancer.
Patients treated with dupilumab experienced fewer asthma exacerbations than the overall population.
Mobile devices may help patients with asthma better manage and control their disease.
Pediatric patients benefited from orally administered injectable dexamethasone for asthma exacerbations.
A survey that was part of the Severe Asthma Research Program found a specific subgroup of patients with asthma who have highly variable asthma control.
Bariatric surgery and continuous positive airway pressure were directly compared as initial treatment modalities for obstructive sleep apnea.
Patients with lung cancer and atherosclerosis diagnosis may benefit from anti-inflammatory therapy with canakinumab.
Self-administered TB therapy should be considered when directly observed therapy is not feasible.
Patients with NSCLC experienced improvements in both function and quality of life with yoga therapy.
Montelukast therapy reduced the need for rescue medication in young children with recurring wheezing illness.
In children with cystic fibrosis, risk for first detection of S aureus and P aeruginosa was greater in those who had received antibiotic prophylaxis.
Salmeterol plus fluticasone was associated with a significant increase in sputum bacterial load in chronic obstructive pulmonary disease, compared to salmeterol alone.
Further research is needed, but the position statement authors support the use of telemedicine as a method of health care delivery.
A randomized trial sought to determine whether the use of titrated positive end-expiratory pressure influenced the 28-day mortality risk in patients with acute respiratory distress syndrome.
The new device features a more ergonomic design with a single-button operation, an intuitive user interface to adjust breath counts, a rechargeable battery, and a display that guides patients through the inhalation process.
The ACCP just released new lung cancer screening guidelines.
Patients who develop pulmonary edema after starting prostacyclin for pulmonary arterial hypertension have a greater risk for mortality.